<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220228054149N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-04-04</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the Effect of Brain Stimulation on Balance</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Transcranial Electrical Stimulation of the Primary Motor and Sensory Cortex on the Feed-forward and Feedback Strategies in Response to Predictable External Perturbations in Patients with Chronic Low Back Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62291</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Individuals are Randomly Divided into Two Groups, Which Will be Done Using Randomization Sequence through Randomization.com and Balanced Block Randomization Method. The Size of the Blocks is 4. Also, for Allocation Concealment, Sealed and Numbered Envelopes are Used, Which are Provided to the Participants by the Secretary, Blinding description: Patients are Randomly Divided into Two Groups of Real Treatment and Unreal(Placebo) Treatment Who do not Know the Type of their Group.
The Information Obtained from the Evaluation of Patients is Categorized by another Person and the Analyst is not Aware of the Grouping of Information.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Low Back Pain due to Radiculopathy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Sensory-motor training in three stages of static, dynamic, functional and real tDCS in time for 4 weeks and 3 times a week (12 sessions), tDCS model neurostim2 model of Medina Teb Gostar company, electrode size 2*4cm, An active electrode (anode) on the M1 region, which according to the international system is 10-20 according to C3 or C4, An active electrode (anode) on the S1 region, which is 2 cm behind the C3 or C4, Reference electrodes (cathode) on the forehead and directly above the eyebrows, Device with an intensity of 1.5 mA and for 20 minutes, The beginning of the current, a period of 10 seconds ramping up, The end of the current, a period of 10 seconds ramping down. Intervention 2: Control group: Sensory-motor exercises in three stages of static, dynamic and functional and tDCS as sham for 4 weeks and 3 times a week (12 sessions), tDCS for 20 minutes: placement of electrodes as intervention group, Device turned on and The intensity increases to the point that the patient feels a tingling sensation, but this feeling will be only for 10 seconds.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Roya Khanmohammdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Corner of Safi Alishah St, Pich e Shemiran, Engheleb Eslami Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>rkhanmohammadi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Roya Khanmohammdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Corner of Safi Alishah St, Pich e Shemiran, Engheleb Eslami Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7753 3939</telephone>
        <email>rkhanmohammadi@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Suffering from LBP for more than 6 (m) or Experience LBP in 3 courses for more than 1 (w) in past 12 (w)
Unilateral Radicular Pain Secondary to Disc Herniation L4/L5 and L5/S1 Diagnosed with MRI
Being Positive of Slump Test or Straight Leg Raise Test or Lasegues’s Test
Pain from Anterior Lateral Part of Leg to Back Area of the Leg Associated with L4/L5 Dermatome to the Posterior Part of the Leg and Heel and Lateral Part of the Foot
Absence of any History of Brain Tumor, Brain Injury or Brain Stroke
Absence of any History of Spondylolysis, Spondylolisthesis and Spinal Cord Fractures
Absence of any History of Neurological Disease such as Parkinson, Cerebellum Disorders or Alzheimer
Absence of any History of Scratches or Cut on the Scalp
Average Pain Score ≥ 4
Oswestry Disability Index &gt; 4
Mini Mental Status Examination ≥ 24
No Pregnancy
Absence of the History of Seizure
No Implantation or Pulse Maker
Absence of the History of Dermal Infection
Age Range: 20 year - 50 year</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participant Dissatisfaction with the Continuation of the Program
Being Absent for more than 2 Sessions or for 3 Times during the whole Procedure
If the Patient is under a Special Therapeutic Program</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Sensory-motor training in three stages of static, dynamic, functional and real tDCS in time for 4 weeks and 3 times a week (12 sessions), tDCS model neurostim2 model of Medina Teb Gostar company, electrode size 2*4cm, An active electrode (anode) on the M1 region, which according to the international system is 10-20 according to C3 or C4, An active electrode (anode) on the S1 region, which is 2 cm behind the C3 or C4, Reference electrodes (cathode) on the forehead and directly above the eyebrows, Device with an intensity of 1.5 mA and for 20 minutes, The beginning of the current, a period of 10 seconds ramping up, The end of the current, a period of 10 seconds ramping down</i_keyword>
      <i_keyword>Control group: Sensory-motor exercises in three stages of static, dynamic and functional and tDCS as sham for 4 weeks and 3 times a week (12 sessions), tDCS for 20 minutes: placement of electrodes as intervention group, Device turned on and The intensity increases to the point that the patient feels a tingling sensation, but this feeling will be only for 10 seconds.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean normalized iEMG of the ipsilateral transversus abdominis, multifidus, and gluteus medius in the four time windows (APA1, APA2, APA1, and CPA2). Timepoint: APA1 : -250 to -100 milliseconds, APA2 : -100 to +50 milliseconds, CPA1 : +50 to +200 milliseconds, CPA2 : +200 to +350 milliseconds. Method of measurement: Electromyography.</prim_outcome>
      <prim_outcome>Mean normalized iEMG of the contralateral transversus abdominis, multifidus, and gluteus medius in four time windows (APA1, APA2, CPA1, and CPA2). Timepoint: APA1 : -250 to -100 milliseconds, APA2 : -100 to +50 milliseconds, CPA1 : +50 to +200 milliseconds, CPA2 : +200 to +350 milliseconds. Method of measurement: Electromyography.</prim_outcome>
      <prim_outcome>Mean onset latency of the ipsilateral transversus abdominis, multifidus, and gluteus medius. Timepoint: The time interval between perturbations (time 0) and the time of onset of muscle activity. Method of measurement: Electromyography.</prim_outcome>
      <prim_outcome>Mean onset latency of the contralateral transversus abdominis, multifidus and gluteus medius. Timepoint: The time interval between perturbations (time 0) and the time of onset of muscle activity. Method of measurement: Electromyography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-02-23</approval_date>
        <contact_name>Ethics committee of School of Nursing, Midwifery and Rehabilitation Tehran University of Medical Sci</contact_name>
        <contact_address>Unit 6, No. 20, First Soleinami Ally, West Safa Ave., Imam Hossein Sq., Tehran Town Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
